Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
This article helps you determine Which Aristocrats ETF Has The Lowest Fees by comparing expense ratios and related costs across top funds.
27,507 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Goldman Sachs foresees a trillion-dollar space economy within the next two decades, underpinned by commercial growth ...
When a top executive sells stock, investors want to know if it signals trouble or simply personal planning. This arti...
Rumors of a setback around Nvidia s Vera Rubin AI rollout stirred investor nerves. In contrast, Jensen Huang has insi...
MU surged with the AI boom, then cooled. This guide asks the practical question: should micron technology stock be bo...
Vet clinics are raising fees as fewer pet visits occur, turning pet ownership into a costlier proposition. The trend ...
Unum Group operates in the steady world of employer benefits and personal protection. If three key trends line up—und...
AMD just struck a landmark deal with a global AI cloud leader. This article breaks down what the contract means for r...
XRP remains range-bound after a volatile 2025, with traders eyeing regulatory clarity and macro trends as potential c...
A billionaire’s online rant against a respected paper can ripple through markets and wallets. This article explains w...
A late 2025 study finds workers would sacrifice up to a quarter of compensation to keep remote work options. The resu...
Block reveals a sweeping AI-focused restructuring, trimming about 40% of its workforce and triggering a strong after-...